LGMD2 B

GPTKB entity

Statements (58)
Predicate Object
gptkbp:instance_of gptkb:muscular_dystrophy
gptkbp:advocacy active
gptkbp:affects proximal muscles
gptkbp:associated_with fatigue
muscle weakness
scoliosis
cardiac issues
joint issues
gptkbp:breeding_range chromosome X
gptkbp:caused_by dystrophin deficiency
gptkbp:clinical_trial ongoing
encouraged
various phases
gait abnormalities
gptkbp:collaborations international
gptkbp:community_involvement increasing
gptkbp:complications respiratory issues
gptkbp:diagnosis genetic testing
clinical evaluation
variable outcomes
gptkbp:disease_management ongoing care
gptkbp:diseases other types of muscular dystrophy
gptkbp:educational_resources available online
gptkbp:exercise_recommendations tailored programs
gptkbp:family often present
gptkbp:first_described_by 1990s
gptkbp:funding available
gptkbp:genetic_counseling_importance high
gptkbp:genetic_studies recommended
widely available
gptkbp:genetic_variants identified
https://www.w3.org/2000/01/rdf-schema#label LGMD2 B
gptkbp:impact varies by individual
gptkbp:inherits_from autosomal recessive
gptkbp:is_involved_in available
gptkbp:is_tested_for elevated creatine kinase
gptkbp:muscle_biopsy_findings myopathic changes
gptkbp:onset_age childhood to early adulthood
gptkbp:pathway muscle fiber degeneration
gptkbp:patient_education crucial
gptkbp:patient_population all ethnicities
gptkbp:patient_quality_of_life affected
gptkbp:player_development variable
gptkbp:prevalence rare
gptkbp:promoter DMD
gptkbp:provides_guidance_on developed
gptkbp:publication numerous
gptkbp:related_to gptkb:LGMD2_A
gptkbp:research_focus gptkb:gene_therapy
gptkbp:research_institutes various universities
gptkbp:symptoms varies by individual
multidisciplinary approach
muscle wasting
gptkbp:treatment ongoing
physical therapy
gptkbp:treatment_research_focus dystrophin restoration
gptkbp:bfsParent gptkb:muscular_dystrophy
gptkbp:bfsLayer 5